deferiprone has been researched along with thiazoles in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Economides, C; Eracleous, E; Kolnagou, A; Kontoghiorghes, GJ | 1 |
Kontoghiorghes, GJ | 2 |
Orvig, C; Patrick, BO; RodrÃguez-RodrÃguez, C; Telpoukhovskaia, MA | 1 |
2 review(s) available for deferiprone and thiazoles
Article | Year |
---|---|
Advances in iron overload therapies. prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations.
Topics: Benzoates; Carboxylic Acids; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Hemochromatosis; Humans; Iron Chelating Agents; Iron Overload; Pyridones; Siderophores; Thalassemia; Thiazoles; Triazoles | 2005 |
Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers.
Topics: Benzoates; Carboxylic Acids; Chelation Therapy; Clinical Trials as Topic; Deferasirox; Deferiprone; Deferoxamine; Drug Evaluation; Drug Therapy, Combination; Forecasting; Hemochromatosis; Humans; Hydroxyethyl Starch Derivatives; Iron Chelating Agents; Iron Overload; Molecular Structure; Pyridones; Starch; Thalassemia; Thiazoles; Transfusion Reaction; Triazoles | 2006 |
2 other study(ies) available for deferiprone and thiazoles
Article | Year |
---|---|
New chelation therapies and emerging chelating drugs for the treatment of iron overload.
Topics: beta-Thalassemia; Carboxylic Acids; Clinical Trials as Topic; Deferiprone; Deferoxamine; Drug Design; Drug Therapy, Combination; Humans; Iron Chelating Agents; Iron Overload; Pyridones; Thiazoles; Transfusion Reaction | 2006 |
Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Benzothiazoles; Binding, Competitive; Blood-Brain Barrier; Catalytic Domain; Cell Survival; Cholinesterase Inhibitors; Deferiprone; Humans; Kinetics; Ligands; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Permeability; Prodrugs; Protein Binding; Pyridones; Thiazoles | 2013 |